Biotech - Spark Newswire - Page 777

Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Read More

3 minute read

The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs

By Shanthi Rexaline

Today, 2:48 AM

Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves.

Read More

1 minute read

Emergent BioSolutions Saus Two Batches Of COVID-19 Vaccine Manufactured By Co. Were Determined Suitable For Use By FDA

Today, 2:48 AM

Emergent BioSolutions Inc. (NYSE:EBS) today announced that two batches of COVID-19 vaccine manufactured by Emergent BioSolutions at its Baltimore Bayview facility were determined to be suitable for use by the U.S.

Read More

1 minute read

Moderna Says No Link Between COVID-19 Jab And Heart Inflammation

By Vandana Singh

Today, 2:48 AM

Moderna Inc (NASDAQ:MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis, based…

Read More

1 minute read

Zynerba’s Zygel Improves Sleep In Children With Severe Epilepsies

By Vandana Singh

Today, 2:48 AM

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) presents sleep data from an open-label Phase 2 trial evaluating Zygel for developmental & epileptic encephalopathies (DEE)…

Read More

1 minute read

Sanofi’s Sutimlimab Hits Endpoint Goal In Rare Anemia Study After FDA Rejection

By Vandana Singh

Today, 2:48 AM

Sanofi SA’s (NASDAQ:SNY) sutimlimab nailed all three of its primary endpoints in its Phase 3 CADENZA study for patients with cold…

Read More

1 minute read

FDA Authorizes 10M JNJ COVID-19 Vaccine Doses, Asks To Discard 60M From Emergent Plant: NYT

By Vandana Singh

Today, 2:48 AM

The FDA has asked Johnson & Johnson (NYSE:JNJ) to discard 60 million doses of its COVID-19 vaccine manufactured at the…

Read More

1 minute read

Eli Lilly’s Internal Probe Clears Its COVID-19 Drug Plant; Memo Says Company Did Not Make False Statements: Reuters

By Vandana Singh

Today, 2:48 AM

Eli Lilly and Co (NYSE:LLY) revealed last month that the U.S. Department of Justice (DOJ) issued a subpoena into its manufacturing…

Read More

1 minute read

Aptose Biosciences Stock Tumbles As Luxeptinib Fails To Impress At EHA2021 Virtual Congress

By Vandana Singh

Today, 2:48 AM

Aptose Biosciences Inc (NASDAQ:APTO) highlighted data from its luxeptinib currently in two Phase 1 a/b trials – one in relapsed or…

Read More

1 minute read

Forma Therapeutics Stock Drops After Disappointing EHA Presentation For Etavopivat In Sickle Cell Disease

By Vandana Singh

Today, 2:48 AM

Forma Therapeutics Holdings Inc (NASDAQ:FMTX) announced new data from its ongoing Phase 1 trial of etavopivat (FT-4202) in sickle cell disease.…

Read More

1 minute read

Protagonist Stock Moves Higher As Rusfertide Shows Durability Of Effect, Symptom Improvements In Blood Cancer Trial

By Vandana Singh

Today, 2:48 AM

Protagonist Therapeutics Inc (NASDAQ:PTGX) has announced updated results from the ongoing Phase 2 study of rusfertide for polycythemia vera (PV), a…